SCHEMBL29090664

SCHEMBL29090664

O=C(O)N1CCC2(CC1)CCN2c1nccc(Cl)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PANK3 Q9H999 1/20 0.40
EPHX2 P34913 1/20 0.39
ALDH1A1 P00352 8/20 0.36
CYP3A4 P08684 5/20 0.36
HSD17B10 Q99714 5/20 0.36
CYP2C19 P33261 4/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
MAPK1 P28482 2/20 0.36
CYP1A2 P05177 5/20 0.35
HPGD P15428 4/20 0.35
TSHR P16473 2/20 0.35
CYP2C9 P11712 4/20 0.34
DYRK1A Q13627 1/20 0.34
CYP2D6 P10635 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
USP2 O75604 1/20 0.33
MMP2 P08253 1/20 0.33
RPS6KA5 O75582 2/20 0.33
RPS6KA4 O75676 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29535614 0.82 POLB (0.46) MEN1KMT2A
SCHEMBL25218506 0.82 POLB (0.46) MEN1KMT2A
Trifluoroacetic Acid SCHEMBL29535601 0.79 HRH4 (0.41) PANK3EPHX2CYP3A4TSHRCYP2D6
Trifluoroacetic Acid SCHEMBL25230709 0.79 HRH4 (0.41) PANK3EPHX2CYP3A4TSHRCYP2D6
SCHEMBL26330928 0.79 CYP2D6 (0.39) PANK3EPHX2ALDH1A1CYP3A4HSD17B10
SCHEMBL2228019 0.79 PANK3 (0.58) PANK3ALDH1A1HSD17B10MAPK1HPGD
SCHEMBL14933786 0.71 EPHX2 (0.51) EPHX2ALDH1A1CYP3A4HSD17B10CYP2C19
SCHEMBL20425052 0.66 PANK3 (0.60) PANK3MAPK1MEN1KMT2A
SCHEMBL15547985 0.66 KMT2A (0.45) CYP3A4CYP2C19CYP2C9MEN1KMT2A
SCHEMBL8514275 0.65 EPHX2 (0.45) EPHX2CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116490186-A Compounds for targeted degradation of RET C4医药公司 2023-07-25 CN disclosed